US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist
  • 372.890
  • +5.530+1.51%
Close Nov 22 16:00 ET
  • 372.890
  • 0.0000.00%
Post 16:48 ET
16.65BMarket Cap16.38P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

United Therapeutics Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
722.81M
748.90M
+26.09M
Beat Est.
+18.61%
+22.89%
+3.61%
EPS
6.42
6.39
-0.03
Miss Est.
+19.41%
+18.77%
-0.54%
Analyst Rating
Strong Buy

Nov 24, 2024

United Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 757.420M--
--2024/Q4-- / 743.011M--
Oct 30, 20242024/Q3748.900M / 722.808M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 757.420M--
--2024/Q4-- / 743.011M--
Oct 30, 20242024/Q3748.900M / 722.808M--
Jul 31, 20242024/Q2714.900M / 691.867M--
May 1, 20242024/Q1677.700M / 624.194M--

Unlock Free Earnings Estimates

United Therapeutics Earnings Reports

  • United Therapeutics | 8-K: United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

    Oct 30 06:37 ET

  • United Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 30 06:37 ET

  • United Therapeutics | 8-K: United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

    Jul 31 06:34 ET

  • United Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 06:34 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data